Global Active Pharma Ingredient Market Insights, Forecast to 2025

Table of Contents

Executive Summary

1 Industry Overview of Active Pharma Ingredient

• 1.1 Definition of Active Pharma Ingredient
• 1.2 Active Pharma Ingredient Segment by Type
  • 1.2.1 Global Active Pharma Ingredient Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Innovative Active Pharmaceutical Ingredients
  • 1.2.3 Generic Active Pharmaceutical Ingredients
• 1.3 Active Pharma Ingredient Segment by Applications
  • 1.3.1 Global Active Pharma Ingredient Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Oncology
  • 1.3.3 Cardiovascular Disease
  • 1.3.4 Diabetes
  • 1.3.5 Central Nervous System and Neurological Disorders
  • 1.3.6 Endocrinology
  • 1.3.7 Other Therapeutic Applications
• 1.4 Global Active Pharma Ingredient Overall Market
  • 1.4.1 Global Active Pharma Ingredient Revenue (2014-2025)
  • 1.4.2 Global Active Pharma Ingredient Production (2014-2025)
  • 1.4.3 North America Active Pharma Ingredient Status and Prospect (2014-2025)
  • 1.4.4 Europe Active Pharma Ingredient Status and Prospect (2014-2025)
  • 1.4.5 China Active Pharma Ingredient Status and Prospect (2014-2025)
  • 1.4.6 Japan Active Pharma Ingredient Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Active Pharma Ingredient Status and Prospect (2014-2025)
  • 1.4.8 India Active Pharma Ingredient Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Active Pharma Ingredient
• 2.3 Manufacturing Process Analysis of Active Pharma Ingredient
• 2.4 Industry Chain Structure of Active Pharma Ingredient

3 Development and Manufacturing Plants Analysis of Active Pharma Ingredient

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Active Pharma Ingredient Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Active Pharma Ingredient
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Active Pharma Ingredient Production and Capacity Analysis
• 4.2 Active Pharma Ingredient Revenue Analysis
• 4.3 Active Pharma Ingredient Price Analysis
• 4.4 Market Concentration Degree

5 Active Pharma Ingredient Regional Market Analysis

• 5.1 Active Pharma Ingredient Production by Regions
  • 5.1.1 Global Active Pharma Ingredient Production by Regions
  • 5.1.2 Global Active Pharma Ingredient Revenue by Regions
• 5.2 Active Pharma Ingredient Consumption by Regions
• 5.3 North America Active Pharma Ingredient Market Analysis
  • 5.3.1 North America Active Pharma Ingredient Production
  • 5.3.2 North America Active Pharma Ingredient Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Active Pharma Ingredient Import and Export
• 5.4 Europe Active Pharma Ingredient Market Analysis
  • 5.4.1 Europe Active Pharma Ingredient Production
  • 5.4.2 Europe Active Pharma Ingredient Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Active Pharma Ingredient Import and Export
• 5.5 China Active Pharma Ingredient Market Analysis
  • 5.5.1 China Active Pharma Ingredient Production
  • 5.5.2 China Active Pharma Ingredient Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Active Pharma Ingredient Import and Export
• 5.6 Japan Active Pharma Ingredient Market Analysis
  • 5.6.1 Japan Active Pharma Ingredient Production
  • 5.6.2 Japan Active Pharma Ingredient Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Active Pharma Ingredient Import and Export
• 5.7 Southeast Asia Active Pharma Ingredient Market Analysis
  • 5.7.1 Southeast Asia Active Pharma Ingredient Production
  • 5.7.2 Southeast Asia Active Pharma Ingredient Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Active Pharma Ingredient Import and Export
• 5.8 India Active Pharma Ingredient Market Analysis
  • 5.8.1 India Active Pharma Ingredient Production
  • 5.8.2 India Active Pharma Ingredient Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Active Pharma Ingredient Import and Export

6 Active Pharma Ingredient Segment Market Analysis (by Type)

• 6.1 Global Active Pharma Ingredient Production by Type
• 6.2 Global Active Pharma Ingredient Revenue by Type
• 6.3 Active Pharma Ingredient Price by Type

7 Active Pharma Ingredient Segment Market Analysis (by Application)

• 7.1 Global Active Pharma Ingredient Consumption by Application
• 7.2 Global Active Pharma Ingredient Consumption Market Share by Application (2014-2019)

8 Active Pharma Ingredient Major Manufacturers Analysis

• 8.1 Teva
  • 8.1.1 Teva Active Pharma Ingredient Production Sites and Area Served
  • 8.1.2 Teva Product Introduction, Application and Specification
  • 8.1.3 Teva Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Novartis
  • 8.2.1 Novartis Active Pharma Ingredient Production Sites and Area Served
  • 8.2.2 Novartis Product Introduction, Application and Specification
  • 8.2.3 Novartis Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Pfizer
  • 8.3.1 Pfizer Active Pharma Ingredient Production Sites and Area Served
  • 8.3.2 Pfizer Product Introduction, Application and Specification
  • 8.3.3 Pfizer Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Johnson & Johnson
  • 8.4.1 Johnson & Johnson Active Pharma Ingredient Production Sites and Area Served
  • 8.4.2 Johnson & Johnson Product Introduction, Application and Specification
  • 8.4.3 Johnson & Johnson Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Mylan
  • 8.5.1 Mylan Active Pharma Ingredient Production Sites and Area Served
  • 8.5.2 Mylan Product Introduction, Application and Specification
  • 8.5.3 Mylan Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 North China Pharmaceutical Group
  • 8.6.1 North China Pharmaceutical Group Active Pharma Ingredient Production Sites and Area Served
  • 8.6.2 North China Pharmaceutical Group Product Introduction, Application and Specification
  • 8.6.3 North China Pharmaceutical Group Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Dr. Reddy’s Laboratories
  • 8.7.1 Dr. Reddy’s Laboratories Active Pharma Ingredient Production Sites and Area Served
  • 8.7.2 Dr. Reddy’s Laboratories Product Introduction, Application and Specification
  • 8.7.3 Dr. Reddy’s Laboratories Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Roche
  • 8.8.1 Roche Active Pharma Ingredient Production Sites and Area Served
  • 8.8.2 Roche Product Introduction, Application and Specification
  • 8.8.3 Roche Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Aurobindo pharma
  • 8.9.1 Aurobindo pharma Active Pharma Ingredient Production Sites and Area Served
  • 8.9.2 Aurobindo pharma Product Introduction, Application and Specification
  • 8.9.3 Aurobindo pharma Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Sun Pharmaceutical Industries
  • 8.10.1 Sun Pharmaceutical Industries Active Pharma Ingredient Production Sites and Area Served
  • 8.10.2 Sun Pharmaceutical Industries Product Introduction, Application and Specification
  • 8.10.3 Sun Pharmaceutical Industries Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Boehringer Ingelheim GmbH
• 8.12 Bayer
• 8.13 BASF
• 8.14 DSM
• 8.15 Zhejiang Medicine
• 8.16 Biocon
• 8.17 Johnson Matthey
• 8.18 Hisun Pharmacy
• 8.19 Cambrex
• 8.20 Shandong Xinhua Pharmaceutical
• 8.21 Lonza group
• 8.22 Huahai Pharmaceutical
• 8.23 Haerbin Pharmaceutical Group
• 8.24 Cipla
• 8.25 Tian Yao
• 8.26 Lupin
• 8.27 North East Pharmaceutical
• 8.28 Albemarle
• 8.29 Shandong Lukang Pharmaceutical
• 8.30 Jiangsu Hengrui Medicine

9 Development Trend of Analysis of Active Pharma Ingredient Market

• 9.1 Global Active Pharma Ingredient Market Trend Analysis
  • 9.1.1 Global Active Pharma Ingredient Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Active Pharma Ingredient Regional Market Trend
  • 9.2.1 North America Active Pharma Ingredient Forecast 2019-2025
  • 9.2.2 Europe Active Pharma Ingredient Forecast 2019-2025
  • 9.2.3 China Active Pharma Ingredient Forecast 2019-2025
  • 9.2.4 Japan Active Pharma Ingredient Forecast 2019-2025
  • 9.2.5 Southeast Asia Active Pharma Ingredient Forecast 2019-2025
  • 9.2.6 India Active Pharma Ingredient Forecast 2019-2025
• 9.3 Active Pharma Ingredient Market Trend (Product Type)
• 9.4 Active Pharma Ingredient Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Active Pharma Ingredient Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List